Open access
Nov 2026
Survival benefits of complete ablation in patients with BCLC stage B hepatocellular carcinoma receiving transarterial chemoembolization and systemic therapy
In patients with BCLC stage B HCC receiving TACE combined with systemic therapy, complete ablation was associated with improved survival and a model to identify patients most likely to benefit from the treatment was developed.
Y. Xiong, Chen Wang, Ting-Ting Mei et al.
· Discover Oncology · 0 citations